IL150019A0 - Process for the alleviation of anxiety - Google Patents

Process for the alleviation of anxiety

Info

Publication number
IL150019A0
IL150019A0 IL15001900A IL15001900A IL150019A0 IL 150019 A0 IL150019 A0 IL 150019A0 IL 15001900 A IL15001900 A IL 15001900A IL 15001900 A IL15001900 A IL 15001900A IL 150019 A0 IL150019 A0 IL 150019A0
Authority
IL
Israel
Prior art keywords
alleviation
anxiety
Prior art date
Application number
IL15001900A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27047894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150019(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL150019A0 publication Critical patent/IL150019A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15001900A 2000-01-18 2000-10-18 Process for the alleviation of anxiety IL150019A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48416100A 2000-01-18 2000-01-18
US09/588,221 US6150365A (en) 1999-08-05 2000-06-06 Anxiety method
PCT/US2000/028800 WO2001052853A1 (en) 2000-01-18 2000-10-18 Anxiety method

Publications (1)

Publication Number Publication Date
IL150019A0 true IL150019A0 (en) 2002-12-01

Family

ID=27047894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15001900A IL150019A0 (en) 2000-01-18 2000-10-18 Process for the alleviation of anxiety

Country Status (22)

Country Link
US (1) US6150365A (ru)
EP (1) EP1248622B1 (ru)
JP (1) JP2003520236A (ru)
KR (1) KR20020073176A (ru)
CN (1) CN1424911A (ru)
AR (1) AR028201A1 (ru)
AT (1) ATE300302T1 (ru)
AU (1) AU775591B2 (ru)
BR (1) BR0016971A (ru)
CA (1) CA2406732A1 (ru)
CZ (1) CZ20022461A3 (ru)
DE (1) DE60021609D1 (ru)
HU (1) HUP0204285A3 (ru)
IL (1) IL150019A0 (ru)
MX (1) MXPA02007003A (ru)
NO (1) NO20023425L (ru)
NZ (1) NZ520823A (ru)
PL (1) PL355966A1 (ru)
RU (1) RU2254132C2 (ru)
TW (1) TWI226831B (ru)
UY (1) UY26440A1 (ru)
WO (1) WO2001052853A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069251A1 (en) * 1999-08-05 2003-04-10 Yevich Joseph P. Antianxiety composition
US20050137206A1 (en) * 1999-08-05 2005-06-23 Yevich Joseph P. Method for treatment of anxiety and depression
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method
US7259289B2 (en) * 2001-03-22 2007-08-21 Merck & Co., Inc. MCH1R deficient mice
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
WO2003010161A1 (en) * 2001-07-24 2003-02-06 Bristol-Myers Squibb Company S-6-hydroxy-buspirone
US6686361B2 (en) 2001-07-24 2004-02-03 Bristol-Myers Squibb Company R-6-hydroxy-buspirone
CN1674904A (zh) * 2002-08-12 2005-09-28 布里斯托尔-迈尔斯斯奎布公司 用于羟基氮哌酮类的改进方法
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
WO2004066987A2 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
WO2012048710A1 (en) 2010-10-15 2012-04-19 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
RU2670272C2 (ru) 2012-04-18 2018-10-22 Контера Фарма Апс Пероральная фармацевтическая композиция, подходящая для повышения эффективности лечения двигательных нарушений
CN107635555B (zh) * 2014-06-26 2021-02-26 康特拉医药公司 丁螺环酮代谢物的用途
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4409223A (en) * 1982-08-06 1983-10-11 Riblet Leslie A Anxiolytic method
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US6008222A (en) * 1996-12-04 1999-12-28 Bristol-Myers Squibb Company Method for oral administration of buspirone and nefazodone
US6150365A (en) * 1999-08-05 2000-11-21 Bristol-Myers Squibb Company Anxiety method

Also Published As

Publication number Publication date
JP2003520236A (ja) 2003-07-02
NO20023425L (no) 2002-09-05
EP1248622B1 (en) 2005-07-27
NZ520823A (en) 2004-05-28
HUP0204285A3 (en) 2004-07-28
HUP0204285A2 (en) 2003-05-28
TWI226831B (en) 2005-01-21
UY26440A1 (es) 2001-08-27
MXPA02007003A (es) 2003-01-28
CN1424911A (zh) 2003-06-18
CZ20022461A3 (cs) 2003-09-17
ATE300302T1 (de) 2005-08-15
BR0016971A (pt) 2002-10-15
WO2001052853A1 (en) 2001-07-26
KR20020073176A (ko) 2002-09-19
RU2002118304A (ru) 2004-01-10
AR028201A1 (es) 2003-04-30
CA2406732A1 (en) 2001-07-26
EP1248622A4 (en) 2004-02-04
EP1248622A1 (en) 2002-10-16
AU775591B2 (en) 2004-08-05
PL355966A1 (en) 2004-05-31
DE60021609D1 (de) 2005-09-01
US6150365A (en) 2000-11-21
AU1213001A (en) 2001-07-31
RU2254132C2 (ru) 2005-06-20
NO20023425D0 (no) 2002-07-17

Similar Documents

Publication Publication Date Title
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
HUP0103291A3 (en) Process for the preparation of citalopram
HUP0000283A3 (en) New process for the production of quetiapine
IL150019A0 (en) Process for the alleviation of anxiety
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
PL359560A1 (en) Process for the isolation of lovastatin
HUP0302579A3 (en) Process for the isolation and purification of epothilones
AU9250401A (en) New process for the production of oxabispidines
AU9168301A (en) Method for the production of melamine
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
EG22846A (en) Process for the preparation of urea
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
HU0104563D0 (en) Process for producing of food-enzymes
HU0100881D0 (en) New process for the preparation of isoindoline
IL152795A0 (en) Method for the production of 2-coumarone and substituted 2-coumarones
EG22758A (en) Process for the preparation of urea
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
EP1293497A4 (en) PROCESS FOR PRODUCING CALCIUM PENTOTHENATE
HRP20000680B1 (en) Process for the preparation of fluconazole
GB0028881D0 (en) Process for the preparation of endo-5-norbornene-2-ol